沙利度胺治疗血管发育异常相关的复发性胃肠道出血：低剂量是一种安全可行的选择吗？
Thalidomide for the treatment of angiodysplasia-related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?
作者信息
Patel Harish, Mehershahi Shehriyar, Shaikh Danial Haris, Makker Jasbir, Nayudu Sureshkumar, Remy Prospere, Chilimuri Sridhar
机构信息
Division of Gastroenterology BronxCare Hospital Center a Clinical Affiliate of Mt Sinai Health Systems and Academic affiliate of Icahn School of Medicine Bronx New York.
Department of Medicine BronxCare Hospital Center a Clinical Affiliate of Mt Sinai Health Systems and Academic affiliate of Icahn School of Medicine Bronx New York.
出版信息
Clin Case Rep. 2019 Oct 23;7(12):2363-2367. doi: 10.1002/ccr3.2501. eCollection 2019 Dec.
Thalidomide is often used for the management of refractory gastrointestinal angiodysplasia (GIAD). The tolerance, toxic profile, and compliance of thalidomide are dose-dependent. The low-dose thalidomide (50 mg) is safe and a viable option for bleeding related to GIAD.
沙利度胺常用于难治性胃肠道血管发育异常（GIAD）的治疗。沙利度胺的耐受性、毒性特征和依从性呈剂量依赖性。低剂量沙利度胺（50毫克）安全，是治疗与GIAD相关出血的可行选择。
Zotero 插件